Close

Guidance for ACADIA Pharmaceuticals (ACAD)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2023 N/A N/A $520.00M – 530.00M $569.00M = Maintained Details
2023 N/A N/A $530.00M – 545.00M $652.10M = Maintained Details
2022 N/A N/A $510.00M – 560.00M $540.70M = Maintained Details
2022 N/A N/A $510.00M – 540.00M $531.00M = Maintained Details
Q3 2021 N/A N/A $480.00M – 515.00M $527.70M = Maintained Details
2020 N/A N/A $440.00M – 470.00M N/A = Maintained Details
2019 N/A N/A $275.00M – 300.00M $297.15M = Maintained Details
2019 N/A N/A $280.00M – 300.00M $291.20M = Maintained Details
2019 N/A N/A $320.00M – 330.00M $292.80M Raised Details
Q2 2018 N/A N/A N/A N/A = Maintained Details
Q1 2018 N/A N/A N/A N/A = Maintained Details
2017 N/A N/A $105.00M – 115.00M N/A = Maintained Details
2017 N/A N/A $124.00M – 127.00M N/A = Maintained Details
Q2 2017 N/A N/A N/A N/A = Maintained Details
Q1 2017 N/A N/A N/A N/A = Maintained Details